Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

173.00
BATS BZX Real-Time Price
As of 1:57pm ET
 -1.80 / -1.03%
Today’s Change
130.09
Today|||52-Week Range
176.85
+6.57%
Year-to-Date
Stocks at Lows as Countdown to Clinton-Trump Debate Begins
12:12pm / TheStreet.com - Paid Partner Content
Amgen (AMGN) Repatha Meets Endpoints in Phase III Study
Sep 21 / Zacks.com - Paid Partner Content
Stock Market News for September 26, 2016
10:51am / Zacks.com - Paid Partner Content
Stock Market News for September 21, 2016
Sep 21 / Zacks.com - Paid Partner Content
Amgen's Biosimilar of Abbvie's Humira Gets FDA Approval
7:41am / Zacks.com - Paid Partner Content
Amgen (AMGN) Parsabiv Gets Positive CHMP Opinion in EU
Sep 19 / Zacks.com - Paid Partner Content
Will Amgen (AMGN) Stock Be Helped By FDA Approval of Humira Biosimilar?
Sep 23 / TheStreet.com - Paid Partner Content
Is This New Market the Biggest Investment Idea of the Decade?
Sep 17 / MotleyFool.com - Paid Partner Content
New Setback for Sanofi's Lantus Increases Need for M&A
Sep 22 / TheStreet.com - Paid Partner Content
Novartis Reports Positive Phase II Data on Migraine Drug
Sep 16 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close174.80
Today’s open174.15
Day’s range172.85 - 174.33
Volume59,180
Average volume (3 months)2,812,269
Market cap$130.8B
Dividend yield2.31%
Data as of 1:57pm ET, 09/26/2016

Growth & Valuation

Earnings growth (last year)+35.22%
Earnings growth (this year)+9.42%
Earnings growth (next 5 years)+8.30%
Revenue growth (last year)+6.49%
P/E ratio17.7
Price/Sales5.83
Price/Book4.69

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences-0.87-1.07%
BIIBBiogen-3.83-1.23%
ILMNIllumina Inc-0.62-0.35%
NBIXNeurocrine Bioscienc...-0.81-1.50%
Data as of 1:58pm ET, 09/26/2016

Financials

Next reporting dateOctober 18, 2016
EPS forecast (this quarter)$2.80
Annual revenue (last year)$21.3B
Annual profit (last year)$6.9B
Net profit margin32.52%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Esteban Santos
Corporate headquarters
Thousand Oaks, California

Forecasts

Search for Jobs